Journal of Polymer & Composites Original Research Special issue
Development of Biodegradable Poly (Lactic-Co-Glycolic Acid) (PLGA) Nanoparticles for Sustained Release of Insulin
Abstract
This research outlines the creation of biodegradable composite nanoparticles made from poly (lactic-co-glycolic acid) (PLGA) designed for the sustained release of insulin. The emphasis is on the interactions between the polymer and the drug at the interface, along with the dynamics of the release matrix. The in vitro release kinetics, surface morphology, encapsulation efficiency, particle size, and polydispersity of insulin-loaded PLGA nanoparticles were analyzed following their production via a double emulsion solvent evaporation method. The nanoparticles composed of the enhanced polymer composite exhibited remarkable colloidal stability, characterized by a narrow polydispersity index of 0.168 ± 0.021 and an average particle size of 185.4 ± 12.6 nm. The encapsulation efficiency was determined to be 78.6 ± 3.2%, while the drug loading was found to be 9.4 ± 0.7%. The establishment of a stable polymer composite system was evidenced by scanning electron microscopy, which revealed smooth, spherical nanoparticles. Insulin was uniformly distributed inside the PLGA polymer matrix without chemical incompatibility, as verified by Fourier transform infrared spectroscopy and differential scanning calorimetry. The first burst release of 12.3 ± 1.8% transpired within the first 6 hours of in vitro release studies, followed by a sustained insulin release of 72.5 ± 3.6% over 120 hours, primarily attributed to diffusion and gradual degradation of the polymer matrix. The produced polymer composite nanoparticles maintained the structural integrity of insulin, exhibiting remarkable storage stability for three months at 4 °C. In conclusion, the results underscore the significance of polymer composite engineering in sophisticated controlled-release drug delivery systems, indicating that PLGA-based polymer composite nanoparticles provide a biodegradable medium for prolonged protein delivery.
Keywords
References (22)
- Alkholief M, Kalam MA, Anwer MK, Alshamsan A. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-co-glycolide) Nanoparticles: Encapsulation, In Vitro Release of Indomethacin and Cytotoxicity against HepG2-Cell. Pharmaceutics. 2022;14(4):870. doi:10.3390/pharmaceutics14040870
- Akhavan Farid E, Davachi SM, Pezeshki-Modaress M, Taranejoo S, Seyfi J, Hejazi I, et al. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles encapsulated in methacrylate coated gelatin with sustained release for specific medical applications. Journal of Biomaterials Science, Polymer Edition. 2020;31(7):910-937. doi:10.1080/09205063.2020.1725863
- Li D, Zheng S, Wei P, Xu Y, Hu W, Ma S, et al. Synchronized long-term delivery of growth hormone and IGF-1 through PLGA nanoparticles. Int J Biol Macromol. 2024;282:136781. doi:10.1016/j.ijbiomac.2024.136781.
- Perez VL, Wirostko B, Korenfeld M, From S, Raizman M. Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications. Journal of Ocular Pharmacology and Therapeutics. 2020;36(2):75-87. doi:10.1089/jop.2019.0034
- Wei P, Xu Y, Zhang H, Wang L. Continued sustained insulin-releasing PLGA nanoparticles modified 3D-Printed PCL composite scaffolds for osteochondral repair. Chemical Engineering Journal. 2021;422:130051. doi:10.1016/j.cej.2021.130051
- Zeb A, Gul M, Nguyen TTL, Maeng HJ. Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research. Journal of Pharmaceutical Investigation. 2022;52(6):683-724. doi:10.1007/s40005-022-00584-w
- Perinelli DR, Cespi M, Bonacucina G, Palmieri GF. PEGylated PLA and PLGA copolymers for the design of drug delivery systems. J Pharm Investig. 2019;49(4):443–458. doi:10.1007/s40005-019-00442-2.
- Keservani RK, Ahire ED, Kesharwani RK, editors. Pharmaceutical Polymer Formulations and its Applications. John Wiley & Sons; 2025 Jul 22.
- Hadiya S, Radwan R, Zakaria M, El-Sherif T, Hamad MA, Elsabahy M. Nanoparticles integrating natural and synthetic polymers for in vivo insulin delivery. Pharmaceutical Development and Technology. 2020;26(1):30-40. doi:10.1080/10837450.2020.1832117
- Xu B, Jiang G, Yu W, Liu D, Liu Y, Kong X, et al. Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin. Materials Science and Engineering: C. 2017;78:420-428. doi:10.1016/j.msec.2017.04.113
- Naskar S, Das SK, Sharma S, Kuotsu K. A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems. Pharmaceutical Nanotechnology. 2021;9(1):36-50. doi:10.2174/2211738508666201214103010
- Pang H, Huang X, Xu ZP, Chen C, Han FY. Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes. Drug Discovery Today. 2023;28(1):103393. doi:10.1016/j.drudis.2022.103393
- Arpaç B, Devrim Gökberk B, Küçüktürkmen B, Özakca Gündüz I, Palabıyık İM, Bozkır A. Design and in vitro/in vivo Evaluation of Polyelectrolyte Complex Nanoparticles Filled in Enteric-Coated Capsules for Oral Delivery of Insulin. Journal of Pharmaceutical Sciences. 2023;112(3):718-730. doi:10.1016/j.xphs.2022.09.018
- Trisopon K, Kittipongpatana OS, Saokham P. Optimizing large porous mannitol-leucine microparticles via spray drying technique. Advanced Powder Technology. 2024;35(7):104512. doi:10.1016/j.apt.2024.104512
- Akhavan Farid E, Davachi SM, Pezeshki-Modaress M, Taranejoo S, Seyfi J, Hejazi I, et al. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles encapsulated in methacrylate coated gelatin with sustained release for specific medical applications. Journal of Biomaterials Science, Polymer Edition. 2020;31(7):910-937. doi:10.1080/09205063.2020.1725863
- Uvaraja VC, Keservani RK, Maurya NK, Pendakur B, Adhoni SA. Formulation and development of gel with essential oils and effect of polymer on their antimicrobial activity. Biochemical and Cellular Archives. 2024;24(2). doi:10.51470/bca.2024.24.2.2269
- Akhavan Farid E, Davachi SM, Pezeshki-Modaress M, Taranejoo S, Seyfi J, Hejazi I, et al. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles. J Biomater Sci Polym Ed. 2020;31(7):910–937. doi:10.1080/09205063.2020.1725863.
- Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II). 2021. doi:10.2174/97816810882351210101
- A. Mumuni M, E. Calister U, Aminu N, C. Franklin K, Musiliu Oluseun A, Usman M, et al. Mucin-Grafted Polyethylene Glycol Microparticles Enable Oral Insulin Delivery for Improving Diabetic Treatment. Applied Sciences. 2020;10(8):2649. doi:10.3390/app10082649
- Mansoor S, Kondiah PPD, Choonara YE, Pillay V. Polymer-Based Nanoparticle Strategies for Insulin Delivery. Polymers. 2019;11(9):1380. doi:10.3390/polym11091380
- Luo W, Bai L, Zhang J, Li Z, Liu Y, Tang X, et al. Polysaccharides-based nanocarriers enhance the anti-inflammatory effect of curcumin. Carbohydrate Polymers. 2023;311:120718. doi:10.1016/j.carbpol.2023.120718
- Rahamtullah, Ahmad A, Mishra R. Polyol and sugar osmolytes stabilize the molten globule state of α-lactalbumin and inhibit amyloid fibril formation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2022;1870(11-12):140853. doi:10.1016/j.bbapap.2022.140853